Nanostructured electrochemical biosensor with aptamer as molecular recognition probe

• US 20080156646A1
• Filed: 11/27/2007
• Published: 07/03/2008
• Est. Priority Date: 12/15/2006
• Status: Abandoned Application

• Current Assignee: Daniel Charles Flynn, Nianqiang Wu, Peter Mico Gannett, William Phillip Petros
• Original Assignee: Daniel Charles Flynn, Nianqiang Wu, Peter Mico Gannett, William Phillip Petros
• Inventors: Petros, William Phillip, Flynn, Daniel Charles, Wu, Nianqiang, Gannett, Peter Mico
• Application Number:
  US11/986,884
• Publication Number:
  US 20080156646A1
• Time in Patent Office: Days
• US Class Current: 204/450
• CPC Class Codes: A61B 5/1473 invasive, e.g. introduced into the body by a catheter A61B5/1482 takes precedence
• CPC Class Codes: C12Q 1/001 Enzyme electrodes
• CPC Class Codes: G01N 33/5438 Electrodes

Abstract

The present invention details a nanostructured electrochemical biosensor based on aptamer as the molecular recognition probe. The biosensor is comprised of an electrochemical cell that can be plugged into an electric controller. This electrochemical biosensor contains a working electrode made of the micro-/nano-scale gold dot array pattern, on which aptamer is immobilized on the surface of the dot array as the molecular recognition probe. The aptamer is labeled with an electrochemical indicator. Reversible binding of an analyte to the aptamer causes the change in the conformation of aptamer, consequently brings the electrochemical indicator close to the electrode surface. This results in the electron transfer from the electrochemical indicator to the electrode, which can be read as a change in output current or potential. The invented biosensor is a portable point-of-care device that has higher sensitivity, allows the measurement of the analyte more rapidly and requires much less sample volume than is presently available with current methods of detection.

Claims

1. An electrochemical cell comprising a non-conductive substrate, a plurality of electrodes connected to said substrate wherein said electrodes are also connected to electrical contacts and at least one of said electrodes is a working electrode wherein said working electrode is a gold dot micro/-nano patterned array with a molecular recognition probe wherein said molecular recognition probe contains an electrochemical redox indicator resulting in said molecular recognition probe binding to an analyte and said molecular recognition probe undergoing a conformational change causing said electrochemical indicator to alter the distance from said gold dot array surface.

2. The electrochemical cell of claim 1 wherein said plurality of electrodes are one or more of a reference electrode, a counter electrode, and a working electrode.

3. The electrochemical cell of claim 2 wherein said reference electrode is Ag/AgCl based.

4. The electrochemical cell of claim 2 wherein said counter electrode is carbon based.

5. The electrochemical cell of claim 1 wherein said non-conductive service is plastic based.

6. The electrochemical cell of claim 1 wherein said molecular recognition probe is an aptamer.

7. The electrochemical cell of claim 6 wherein said aptamer is a ssDNA or sRNA.

8. The electrochemical cell of claim 6 wherein said aptamer is [Seq1].

9. The electrochemical cell of claim 1 wherein said electrochemical redox indicator is methylene blue.

10. The electrochemical cell of claim 1 wherein said electrochemical redox indicator is phenanthroline Fe(II).

11. The electrochemical cell of claim 1 further comprising an electric controller capable of a digital display of a change in output current or potential when said electrochemical indicator changes distance from said gold dot array.

12. A method to reversibly bind cisplatin in a serum comprising exposing an electrochemical cell to a serum wherein said electrochemical cell contains a working electrode, a reference electrode and a counter electrode connected to a non-conductive substrate and electrical contacts, binding an the aptamer [Seq1] labeled with an electrochemical redox indicator wherein said aptamer is immobilized on a micro/nano patterned gold dot array working electrode surface of an electrochemical cell wherein cisplatin binds to said aptamer causing a conformational change in said aptamer causing a change in the current density to said electrode.

13. The method to reversibly bind cisplatin in a serum of claim 12 further comprising implanting said electrochemical cell into a subject.

14. A method of making an electrochemical cell comprising preparing an aptamer, adding a redox active group to said aptamer, attaching said aptamer to a gold dot micro/-nano patterned arrayworking electrode.

15. The method of making an electrochemical cell of claim 14 further comprising adding a membrane with a pore size of about 1000 MW across the inlet of said electrochemical cell.